On May 31, 2023, Lyra Therapeutics, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3626 USD | -2.66% | -30.47% | -93.08% |
05-07 | Jefferies Downgrades Lyra Therapeutics to Hold, Price Target at $0.50 | MT |
05-07 | HC Wainwright Downgrades Lyra Therapeutics to Neutral From Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-93.08% | 22.11M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+42.27% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- LYRA Stock
- News Lyra Therapeutics, Inc.
- Lyra Therapeutics, Inc. announced that it has received $44.11725 million in funding